共查询到20条相似文献,搜索用时 46 毫秒
1.
2.
3.
郭述真 《人人健康:医学导刊》2009,(24):42-45
子宫颈癌的发病率仅次于乳腺癌,居妇女恶性肿瘤的第二位,在某些国家则高居榜首。据世界卫生组织统计:全球每年新发子宫颈癌病例近50万人,死亡约20多万人,发展中国家是发达国家的6倍。我国妇女的子宫颈癌发病率、死亡率约占世界的1/3,山西省是国内高发省份。 相似文献
4.
宫颈癌是最常见的女性恶性肿瘤之一,发病率居乳腺癌之后,为女性恶性肿瘤第二位,妇科恶性肿瘤之榜首。全世界每年大约有50万的新发病例,发展中国家约占80%,据世界卫生组织统计,我国每年新发病例约13.15万例,全世界的1/4。因此,提高健康意识, 相似文献
5.
6.
宫颈癌是常见的妇科恶性肿瘤之一,其发病率在女性恶性肿瘤中居第2位〔1〕。全世界每年约有46.6万新发病例,其中约有13万在中国〔2〕。每位妇女每2~5年至少做一次筛查,可以大大降低宫颈癌的发生率和死亡率〔3〕。本文以湖北省武汉市部分高等院校、大型企业、街、道社区卫生机构辖区内25岁~的已婚妇女和卫生机构的医护人员作为研究对象,对妇女参与并接受宫颈刮片筛查的影响因素进行分析,为提高宫颈刮片筛查率和加强干预措施提供依据。 相似文献
7.
8.
9.
子宫颈癌是妇女最常见的恶性肿瘤之一。在我国,居女性恶性肿瘤的第二位。据统计,我国每年约有13万新发病例,约占全世界新发病例的1/3,每年约有5万人死于宫颈癌,它已经成为威胁妇女健康的一大杀手。 相似文献
10.
吴成 《中国计划生育学杂志》2012,20(10):717-719
<正>1子宫内膜癌筛查的必要性子宫内膜癌是女性生殖道三大恶性肿瘤之一。据美国癌症协会估计,2012年美国子宫内膜癌新发病例数为47130例,占女性恶性肿瘤总数的6%;发病率居美国女性恶性肿瘤第4位(前3位分别是乳腺癌、肺癌、结直肠癌),妇科恶性肿瘤第1位;死亡病例为8010例,占美国女性恶性肿瘤死亡例数的3%,居女性恶性肿瘤的第8位。在美国,反对在无症状人群中进行子宫内膜癌筛查的理由主要是:① 相似文献
11.
12.
13.
14.
目的将现代信息技术引入宫颈癌、乳腺癌筛查工作,以提高两癌筛查工作的服务和管理水平。方法基于北京市妇幼保健信息系统二期开发建设,对两癌筛查子系统进行升级改造。结果两癌筛查信息系统可以实现从个人基本信息采集、筛查及诊断结果录入,到可疑病例确诊、治疗、随访等全过程的信息化,实现信息共享,提高了工作效率,提升了两癌筛查系统管理水平,为各级管理者提供及时有效的信息数据。结论将信息技术引入两癌筛查工作领域有其必要性,两癌筛查信息管理系统可以优化工作流程,提升妇幼保健信息管理层次,提高工作效率和质量。 相似文献
15.
Hae-Ra Han Boyun Huh Miyong T. Kim Jiyun Kim Tam Nguyen 《Journal of health communication》2014,19(10):267-284
For many people limited health literacy is a major barrier to effective preventive health behavior such as cancer screening, yet a comprehensive health literacy measure that is specific to breast and cervical cancer screening is not readily available. The purpose of this article is to describe the development and testing of a new instrument to measure health literacy in the context of breast and cervical cancer screening, the Assessment of Health Literacy in Cancer Screening (AHL-C). The AHL-C is based on Baker's conceptualization of health literacy and modeled from the two most popular health literacy tests, the Rapid Estimate of Adult Literacy in Medicine and the Test of Functional Health Literacy in Adults. The AHL-C consists of four subscales; print literacy, numeracy, comprehension, and familiarity. We used baseline data from 560 Korean American immigrant women who participated in a community-based randomized trial designed to test the effect of a health literacy-focused intervention to promote breast and cervical cancer screening. Rigorous psychometric testing supports that the AHL-C is reliable, valid, and significantly correlated with theoretically selected variables. Future research is needed to test the utility of the AHL-C in predicting cancer screening outcomes. 相似文献
16.
17.
《临床医学工程》2019,(12):1691-1692
目的研究人乳头瘤病毒(HPV)相关宫颈癌的精准筛查和治疗。方法选择我院2018年10月至2019年5月收治的HPV相关宫颈癌患者182例,根据不同筛查方法分为两组各91例。对照组采用核酸快速导流杂交基因芯片技术筛查,研究组采用荧光PCR分型定量技术筛查,比较两组的检测结果。结果对照组检测出83例(91.21%) HPV高危型感染患者,其中单一感染61例,多重感染22例。研究组检测出85例(93.41%) HPV高危型阳性患者,其中单通道阳性63例,两通道阳性18例,三通道阳性4例。两组的阳性率比较,差异无统计学意义(P>0.05)。结论对于HPV相关宫颈癌可采取核酸快速导流杂交基因芯片技术、荧光PCR分型定量技术进行筛查,但荧光PCR分型定量技术的优势较明显,筛查范围较广,有利于患者的及时治疗。 相似文献
18.
Anderson Chuck 《Value in health》2010,13(2):169-179
ObjectivesThe aim of this study is to assess the cost-effectiveness of 21 alternative cervical cancer screening (CCS) strategies.MethodsA cohort simulation model was developed to determine from a health systems perspective the cost-effectiveness of the 21 alternative CCS strategies that incorporated combinations of Papanicolaou's smear test (PAP), liquid-based cytology (LBC) or human papillomavirus deoxyribonucleic acid (HPV-DNA) testing. The model was calibrated to categorize total costs into four budgetary authorities: testing, physician, inpatient, and outpatient services. Within each category, alternative screening strategies were contrasted in terms of their cost impacts and the percent change calculated within each category. Epidemiologic data and costs were derived from administrative health databases. Estimates of test characteristics and quality-adjusted life years (QALYs) were derived from available literature.ResultsThree-year screening with PAP and HPV-DNA triage testing for women older than 30 years of age (3-year PAP + HPV + PAP-age) is less costly and more effective saving $16,078 per additional QALY gained. Although there was an associated net cost decrease of 4.2% driven by a reduction in testing and physician costs of 22.1% and 18.6%, respectively, there is a cost increase of 0.8% and 27.7% in inpatient and outpatient services, respectively.ConclusionThere is economic evidence to support adopting 3-year PAP + HPV + PAP-age. Budgetary resources can potentially be shifted from testing and physician services to fund the additional resource requirements for inpatient and outpatient services. 相似文献
19.
目的研究评价几种常用的诊断方法在宫颈癌筛查中的作用。方法2005年10月~2006年3月共为756名符合标准的妇女进行普查,分别进行子宫颈照相,巴氏涂片或液基细胞学筛查,部分对象行高危型HPV—DNA检测,根据细胞学。HPV—DNA结果阳性及阴道镜图象异常情况,在阴道镜下取活检行病理学检查。结果液基细胞学的诊断效果最好,灵敏度,特异度,阴性预测值,阳性预测值,符合率,分别为:75.0%、96.9、75.0%、96.9%、94.9%,液基细胞学对子宫颈癌前病变的检出率高于巴氏涂片,差异有显著性(P〈0.05)。结论最佳方案:液基细胞学(LCT)联合高危型HPV—DNA检测可提高筛查效果。 相似文献